drugset / Trial / NCT02924324

Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients

NCT02924324 ↗

RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to identify whether or not the addition of a numbing medicine that is injected directly into the site of the bone marrow procedure can reduce pain and the use of opioid pain medication after bone marrow procedures. The addition of this medicine, called ropivacaine, is the experimental part of this study. This is the first time ropivacaine will be directly injected into the bone marrow site at MSKCC Pediatrics.

Timeline

Start
2016-10
Primary completion
2019-11
Completion
2019-11

Outcome

Missed primary endpoint

paper There was no significant difference in percentage of participants requiring opioids with GA versus GA + LA (24% vs 20%, P = .5). PMID 31366683 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified — Other

Indications